Hepatitis C
Showing NaN - NaN of 57
Hepatitis C Trial in Chicago (Peginterferon alfa-2a, Ribavirin, telaprevir)
Terminated
- Hepatitis C
- Peginterferon alfa-2a
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
May 11, 2016
Hepatitis C, HCV, Chronic Hepatitis C Infection Trial in United States (ABT-450, ABT-072, Ribavirin)
Hepatitis C, Human Immunodeficiency Virus Trial in Puerto Rico, United States (SOF, RBV)
Completed
- Hepatitis C
- Human Immunodeficiency Virus
-
Birmingham, Alabama
- +26 more
Nov 14, 2014
Hepatitis C Trial in Belgium, United States (ACH-0141625 (Sovaprevir), Placebo, Pegylated Interferon alpha-2a)
Completed
- Hepatitis C
- ACH-0141625 (Sovaprevir)
- +3 more
-
Los Angeles, California
- +17 more
Sep 8, 2014
Hepatitis C Trial in Worldwide (biological, drug, other)
Completed
- Hepatitis C
- Pegylated Interferon Alfa 2a
- +3 more
-
Birmingham, Alabama
- +115 more
Jul 16, 2014
Hepatitis, Hepatitis C Trial in Worldwide (Filibuvir, Placebo)
Hepatitis C, HIV Trial in Worldwide (telaprevir or matching , peginterferon alfa-2a, ribavirin (fixed dose))
Completed
- Hepatitis C
- HIV Infections
- telaprevir or matching placebo
- +3 more
-
Beverly Hills, California
- +15 more
Aug 2, 2013
Hepatitis C Virus Infection in HIV-Infected Children
Completed
- HIV Infections
- Hepatitis C
-
Birmingham, Alabama
- +38 more
Oct 30, 2012